These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 2143627)
1. Mifepristone (RU 486) failure in an ovarian heterotopic pregnancy. Levin JH; Lacarra M; d'Ablaing G; Grimes DA; Vermesh M Am J Obstet Gynecol; 1990 Aug; 163(2):543-4. PubMed ID: 2143627 [TBL] [Abstract][Full Text] [Related]
2. [Effect of an antiprogesterone (RU 486) on extra-uterine pregnancy]. Paris FX; Henry-Suchet J; Tesquier L; Dacquin G; Pez JP; Loysel T; Loffredo V; Roger M; De Brux J Rev Fr Gynecol Obstet; 1986 Nov; 81(11):607-9. PubMed ID: 3797942 [No Abstract] [Full Text] [Related]
3. [Histopathology appearance of intrauterine residue after medical abortion by mifepristone and prostaglandin analogue]. Xu MF; Jin YC; Cen HX Zhonghua Fu Chan Ke Za Zhi; 1994 Dec; 29(12):739-41, 763. PubMed ID: 7712904 [TBL] [Abstract][Full Text] [Related]
4. [Induced termination of second and third trimester pregnancy in women with scarred uterus]. Zou LY; Fan L Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):17-21. PubMed ID: 20367920 [TBL] [Abstract][Full Text] [Related]
5. [Laparoscopic treatment of ovarian pregnancy]. Langebrekke A; Bakke T Tidsskr Nor Laegeforen; 1990 Jan; 110(2):208. PubMed ID: 2137267 [TBL] [Abstract][Full Text] [Related]
6. [A phase III multicentre study on medical termination of early pregnancy with two regimens of mifepristone followed by PG05]. Sang G; Shao Q; Wu Y Zhonghua Yi Xue Za Zhi; 1996 May; 76(5):325-30. PubMed ID: 9206191 [TBL] [Abstract][Full Text] [Related]
7. Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy. Swahn ML; Ugocsai G; Bygdeman M; Kovacs L; Belsey EM; Van Look PF Hum Reprod; 1989 Jan; 4(1):21-8. PubMed ID: 2651472 [TBL] [Abstract][Full Text] [Related]
8. The role of laparoscopy in the diagnosis and management of heterotopic pregnancies. Louis-Sylvestre C; Morice P; Chapron C; Dubuisson JB Hum Reprod; 1997 May; 12(5):1100-2. PubMed ID: 9194674 [TBL] [Abstract][Full Text] [Related]
9. A retrospective study of estrogen in the pretreatment for medical management of early pregnancy loss and the inference from intrauterine adhesion. Cao C; Zhou Q; Hu Z; Shu C; Chen M; Yang X Eur J Med Res; 2022 Jul; 27(1):129. PubMed ID: 35879721 [TBL] [Abstract][Full Text] [Related]
10. RU 486 (mifepristone). Grimes DA West J Med; 1992 Jun; 156(6):648. PubMed ID: 1615658 [No Abstract] [Full Text] [Related]
12. Mifepristone (RU 486) induces embryo expulsion in first trimester non-developing pregnancies: a prospective randomized trial. Lelaidier C; Baton-Saint-Mleux C; Fernandez H; Bourget P; Frydman R Hum Reprod; 1993 Mar; 8(3):492-5. PubMed ID: 8473474 [TBL] [Abstract][Full Text] [Related]
13. Medical therapy (methotrexate and mifepristone) alone or in combination with another type of therapy for the management of cervical or interstitial ectopic pregnancy. Gómez García MT; Aguarón Benitez G; Barberá Belda B; Callejón Rodríguez C; González Merlo G Eur J Obstet Gynecol Reprod Biol; 2012 Nov; 165(1):77-81. PubMed ID: 22771188 [TBL] [Abstract][Full Text] [Related]
14. Transplacental passage of mifepristone and its influence on maternal and fetal steroid concentrations in the second trimester of pregnancy. Hill NC; Selinger M; Ferguson J; MacKenzie IZ Hum Reprod; 1991 Mar; 6(3):458-62. PubMed ID: 1955558 [TBL] [Abstract][Full Text] [Related]
15. Ectopic pregnancy: the laparoscope as a diagnostic aid. Esposito JM J Reprod Med; 1980 Jul; 25(1):17-24. PubMed ID: 6447205 [No Abstract] [Full Text] [Related]
17. Rare association of ovarian implantation site for patients with heterotopic and with primary ectopic pregnancies after ICSI and blastocyst transfer. Oliveira FG; Abdelmassih V; Costa AL; Balmaceda JP; Abdelmassih S; Abdelmassih R Hum Reprod; 2001 Oct; 16(10):2227-9. PubMed ID: 11574520 [TBL] [Abstract][Full Text] [Related]
18. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. Peyron R; Aubény E; Targosz V; Silvestre L; Renault M; Elkik F; Leclerc P; Ulmann A; Baulieu EE N Engl J Med; 1993 May; 328(21):1509-13. PubMed ID: 8479487 [TBL] [Abstract][Full Text] [Related]
19. Persistent ascites after ovarian hyperstimulation syndrome and administration of mifepristone (RU 486) for the termination of pregnancy. Gnoth C; Halbe E; Freundl G Arch Gynecol Obstet; 2003 Apr; 268(1):65-8. PubMed ID: 12673480 [TBL] [Abstract][Full Text] [Related]